James Justin Hutchens Net Worth

The estimated Net Worth of James Justin Hutchens is at least $3.73 Million dollars as of 10 February 2016. James Hutchens owns over 10,000 units of Ventas Inc stock worth over $2,342,342 and over the last 16 years James sold VTR stock worth over $1,389,647.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

James Hutchens VTR stock SEC Form 4 insiders trading

James has made over 19 trades of the Ventas Inc stock since 2009, according to the Form 4 filled with the SEC. Most recently James bought 10,000 units of VTR stock worth $274,700 on 10 February 2016.

The largest trade James's ever made was exercising 200,000 units of Ventas Inc stock on 8 January 2015 worth over $12,580,000. On average, James trades about 15,554 units every 47 days since 2009. As of 10 February 2016 James still owns at least 35,854 units of Ventas Inc stock.

You can see the complete history of James Hutchens stock trades at the bottom of the page.

What's James Hutchens's mailing address?

James's mailing address filed with the SEC is C/O VENTAS, INC., 353 NORTH CLARK ST., SUITE 3300, CHICAGO, IL, 60654.

Insiders trading at Ventas Inc

Over the last 20 years, insiders at Ventas Inc have traded over $3,514,800,086 worth of Ventas Inc stock and bought 14,500 units worth $790,035 . The most active insiders traders include Holdings Llc Lazard Alterna..., Matthew J Lustig, and Senior Quarters Llc Lazard .... On average, Ventas Inc executives and independent directors trade stock every 24 days with the average trade being worth of $15,339,027. The most recent stock trade was executed by Peter J. Bulgarelli on 10 September 2024, trading 7,500 units of VTR stock currently worth $487,875.

What does Ventas Inc do?

celebrating our 20th anniversary in 2018, ventas is an s&p; 500 company and leading real estate investment trust (reit). as the leading capital provider for healthcare real estate with more than $40 billion of investments under our belt, we own communities where patients and their families receive health and healing; where world class researchers discover treatments for disease; and where seniors live with dignity. our diverse property portfolio combines seniors housing, life science research and innovation centers, medical office buildings, health system complexes, and post-acute care facilities. thanks to our financial strength and liquidity, our stock and robust dividend provides secure retirement savings and income to pensioners, firefighters, teachers and individuals around the world. ventas takes our esg (environment, social & governance) commitments seriously, emphasizing strong corporate governance; encouraging community engagement through social and financial support to the co

Complete history of James Hutchens stock trades at Healthpeak Properties, National Health Investors, New Senior Investment Inc, and Ventas Inc

Ventas Inc executives and stock owners

Ventas Inc executives and other stock owners filed with the SEC include:

• Debra Cafaro,
  Chairman of the Board, Chief Executive Officer
• John Cobb,
  Executive Vice President, Chief Investment Officer
• Robert Probst,
  Chief Financial Officer, Executive Vice President
• Debra A. Cafaro,
  Chairman & CEO
• Peter Bulgarelli,
  Executive Vice President and President and Chief Executive Officer, Lillibridge Healthcare Services, Inc.
• Carey Shea Roberts J.D.,
  Exec. VP, Gen. Counsel, Corp. Sec. and Ethics & Compliance Officer
• Robert F. Probst,
  Exec. VP & CFO
• John D. Cobb,
  Exec. VP & Chief Investment Officer
• Peter J. Bulgarelli,
  Exec. VP of Office
• J. Justin Hutchens,
  Exec. VP of Sr. Housing
• James Shelton,
  Presiding Independent Director
• Melody Barnes,
  Independent Director
• Richard Gilchrist,
  Independent Director
• Roxanne Martino,
  Independent Director
• Robert Reed,
  Independent Director
• Walter Rakowich,
  Independent Director
• Jay Gellert,
  Independent Director
• Matthew Lustig,
  Independent Director
• Sean Nolan,
  Independent Director
• Juan Sanabria,
  IR Contact Officer
• Marguerite Nader,
  Independent Director
• Louise Adhikari,
  VP of Marketing & Corp. Communications
• Bhavana Devulapally,
  Sr. VP & Chief Information Officer
• Ankit Patel,
  Sr. VP of Corp. Fin.
• Gregory R. Liebbe,
  Sr. VP, Chief Accounting Officer & Controller
• Glenn J Rufrano,
  Director
• Gregory R Liebbe,
  SVP, Chief Accounting Officer
• T Richard Riney,
  Exec.V.P., General Counsel
• Todd W. Lillibridge,
  EVP, Medical Prop. Operations
• Douglas M Pasquale,
  Director
• Michael J Embler,
  Director
• Joe Vasquez Jr. Rodriguez,
  Director
• Theodore Bigman,
  Director
• Carey S. Roberts,
  EVP and GC
• Christopher Taylor Hannon,
  Director
• Keith Travis George,
  Controller & Chief Acctg Off.
• Douglas Ii Crocker,
  Director
• Senior Quarters Llc Lazard ...,
  
• Julie M. Dreixler,
  SVP-Human Resources
• Holdings Llc Lazard Alterna...,
  
• Raymond J Lewis,
  Sr.VP.Chief Investment Officer
• Sheli Z Rosenberg,
  Director
• Vincent M. Cozzi,
  SVP Medical Office Properties
• Joseph G. Kurzydym,
  SVP, Medical Prop. Operations
• Senior Quarters Llc Lazard ...,
  
• Richard A Schweinhart,
  EX VP, Chief Financial Officer
• Ronald G Geary,
  Director
• Brian K Wood,
  SVP-Tax
• Thomas C Theobald,
  Director
• Timothy A Doman,
  Sr. V.P., Asset Management
• Robert J Brehl,
  Controller & Chief Acctg Off.
• Robert D Paulson,
  Director
• Lisa M Brush,
  SVP-Sr. Hsg. Dev. & Op
• Maurice S Smith,
  Director
• Sumit Roy,
  Director
• James Justin Hutchens,
  EVP Senior Housing and CIO